Cation substitution in cationic phosphonolipids: A new concept to improve transfection activity and decrease cellular toxicity

Journal of Medicinal Chemistry

Volumn 43, Issue 24, 2000, Pages 4617-4628

  Floch, V ^a   Loisel, S ^a   Guenin, E ^b   Herve, A C ^b   Clement, J C ^b   Yaouanc, J J ^b   Des Abbayes, H ^b   Ferec, C ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

^b Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; PHOSPHONOLIPID; UNCLASSIFIED DRUG;

ARTICLE; CATION TRANSPORT; CYTOTOXICITY; DNA TRANSFER; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL; HYDROPHOBICITY; PROTEIN EXPRESSION;

EID: 0034736033     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000006z     Document Type: Article

References (37)

1. Cationic liposomes for gene therapy
2. Cationic liposome-mediated gene transfer
3. Considerations for the design of improved cationic amphiphile-based transfection reagents
4. Structural and functionnal analysis of cationic transfection lipids: The hydrophobic domain
5. Detailed analysis of structure and formulations of cationic lipids for efficient gene transfer to the lung
6. The counterion influence on cationic lipid-mediated transfection of plasmid DNA
7. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
8. Cationic phosphonolipids as non viral vectors for DNA transfection
9. Novel cationic phosphonolipids agents for gene transfer to a cystic fibrosis cell line
10. Cationic phosphonolipids as non viral vectors for DNA transfection in hematopoietic cell lines and CD34+ cells
11. Transgene expression kinetics after transfection with cationic phosphonolipids in hematopoietic non adherent cells
12. Cationic phosphonolipids as non viral gene transfer agents in lungs of mice
13. Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency
14. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy
15. Polyethylenimine-based intravenous delivery of transgenes to mouse lung
16. A novel tetraester construct that reduces cationic lipid-associated cytotoxicity. Implications for the onset of cytotoxicity
17. New biocompatible cationic amphiphiles derivative from glycine betaine: A novel family of efficient non viral gene transfer agents
18. Novel pyridinium surfactants for efficient, non toxic in vitro gene delivery
19. Novel cationic liposomes for DNA-transfection with high efficiency and low toxicity
20. Converting an alcohol to an amine in a cationic lipid dramatically alters the co-lipid requirement, cellular transfection activity and the ultrastructure of DNA-cytofectin complexes
21. A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery
22. Synthesis, activity, and structure-activity relationship studies of novel cationic lipids for DNA transfer
23. Polyamine analogues of 3β-[N-(N',N'-dimethylaminoethane)carbamoyl]-cholesterol (DC-Chol) as agents for gene delivery
24. Synthesis, antitumor activity, and tolerability of phospholipids containing nitrogen homologues
25. Cationic phosphonolipids containing quaternary phosphonium and arsonium for DNA transfection with good efficiency and low cellular toxicity
26. A free radical approach to functionalization of phosphonates utilizing novel 2- and 3-phosphonyl radicals
27. The facile dealkylation of phosphonic acid dialkyl esters by bromotrimethylsilane
28. Expedient and highyield synthesis of alkylphosphonyl dichlorides under mild, neutral conditions: Reaction of bis(trimethylsilyl)alkyl phosphonates with oxalyl chloride/dimethylformamide
29. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
30. Phosphonolipids as non viral vectors for gene therapy
31. Interactions of mammalial cells with lipid dispersions containing novel metabolizable cationic amphiphiles
32. Factors influencing the efficiency of cationic liposome mediated intravenous gene delivery
33. Characterization of cationic liposome mediated gene transfer in vivo by intravenous administration
34. Improved DNA: Liposome complexesfor increased systemic delivery and gene expression
35. Oncogene-mediated propagation of tracheal epithelial cells from two cystic fibrosis fetuses with different mutations. Characterization of CFT-1 and CFT-2 cells in culture
36. Systemic gene therapy: Biodistribution and long-term expression of a transgene in mice